EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8

Wan Du, Volkan Ergin, Corena Loeb, Mingqian Huang, Stewart Silver, Ariel Miura Armstrong, Zaohua Huang, Channabasavaiah B Gurumurthy, Hinrich Staecker, Xuezhong Liu, Zheng-Yi Chen

Molecular Therapy · 2023

DOI: 10.1016/j.ymthe.2023.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2023. Verfasst von Wan Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston,…. Hauptthemen laut MEDLINE: Deafness, Serine Endopeptidases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with mutations in the TMPRSS3 gene suffer from recessive deafness DFNB8/DFNB10. For these patients, cochlear implantation is the only treatment option. Poor cochlear implantation outcomes are seen in some patients. To develop biological treatment for TMPRSS3 patients, we generated a knockin mouse model with a frequent human DFNB8 TMPRSS3 mutation. The Tmprss3A306T/A306T homozygous mice display delayed onset progressive hearing loss similar to human DFNB8 patients. Using AAV2 as a vector to carry a human TMPRSS3 gene, AAV2-hTMPRSS3 injection in the adult knockin mouse inner ear results in TMPRSS3 expression in the hair cells and the spiral ganglion neurons. A single AAV2-hTMPRSS3 injection in Tmprss3A306T/A306T mice of an average age of 18.5 months leads to sustained rescue of the auditory function to a level similar to wild-type mice. AAV2-hTMPRSS3 delivery rescues the hair cells and the spiral ganglions neurons. This study demonstrates successful gene therapy in an aged mouse model of human genetic deafness. It lays the foundation to develop AAV2-hTMPRSS3 gene therapy to treat DFNB8 patients, as a standalone therapy or in combination with cochlear implantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeafnessSerine EndopeptidasesAdultInfantMembrane ProteinsHumansHearing Loss, SensorineuralMiceHearingGenetic TherapyAnimalsNeoplasm Proteins

Stichwörter der Autor:innen

AAVDFNB10DFNB8TMPRSS3aged mousegene therapygenetic hearing losshair cellsrecessivespiral ganglion neurons

Substanzen

Serine EndopeptidasesMembrane ProteinsTMPRSS3 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA 02115, USA; Department of Otolaryngology-Head and Neck Surgery, Gr…
  • Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Mouse Genome Engineering Core Facility, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Kansas University Center for Hearing and Balance Disorders, Kansas City, KS 66160, USA.
  • Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: x.liu1@med.miami.edu.

Förderung

  • NIDCD NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • US Department of Defense
  • NIDCD

Zitieren

APA

Du, W., Ergin, V., Loeb, C., Huang, M., Silver, S., Armstrong, A. M., Huang, Z., Gurumurthy, C. B., Staecker, H., Liu, X., & Chen, Z. Y. (2023). Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.05.005

Vancouver

Du W, Ergin V, Loeb C, Huang M, Silver S, Armstrong AM, et al. Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8. Molecular Therapy. 2023. doi:10.1016/j.ymthe.2023.05.005

BibTeX
@article{Du2023,
  author = {Du, Wan and Ergin, Volkan and Loeb, Corena and Huang, Mingqian and Silver, Stewart and Armstrong, Ariel Miura and Huang, Zaohua and Gurumurthy, Channabasavaiah B and Staecker, Hinrich and Liu, Xuezhong and Chen, Zheng-Yi},
  title = {Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8},
  journal = {Molecular Therapy},
  year = {2023},
  doi = {10.1016/j.ymthe.2023.05.005}
}
Kostenlos starten →